Global Biologics Market: Drivers, Opportunities, Trends, and Forecasts 2018-2024

Biologics market also referred as biological drug or biopharmaceuticals are therapeutic entities composed of complex molecules made from living cells of microorganisms, humans or animals and are generally produced using recombinant DNA technology. Biologics market products comprise of wide range of vaccines, monoclonal antibodies, recombinant proteins/hormones, cell therapy and gene therapy. These genetically engineered medications prevent, treat or cure various disease types such as infectious disease, cancer, autoimmune disease and chronic kidney disease.

Increasing incidence of chronic and autoimmune diseases across the globe, increasing obtainability of advanced diagnostics, various blockbuster biologics are losing patents, technological advancements, and increasing government initiatives are some of the factors driving global biologics market. However, the difficult manufacturing process, high costs of the drug and development process, and stringent approval process are hampering the growth of the biologics market.

Monoclonal antibodies, Recombinant Hormones/proteins, cell therapy, vaccines and gene therapy are various products considered and monoclonal antibodies occupied major market share in 2017. Cell therapy and gene therapy segment is expected to have high growth potential, and majority of the companies are investing in this segment for the development of molecule to treat the rare disease, for which no other treatments are available. North America occupied a major market share of global biologics market followed by Europe, Asia Pacific and Rest of the world. The Biologics market growth in this region is due to the presence of many established players, intensive R&D activities, the huge number of ongoing clinical trials and higher demand for the product to treat various disease. The APAC region is expected to witness exponential growth during the forecasted period due to increasing disposable income, enormous patient pool, and rising healthcare expenditure. Some of the key vendors in the global biologics market are AbbVie Inc., Bayer AG, Amgen Inc, F. Hoffmann-La Roche, Novartis AG, Novo Nordisk AS, Johnson and Johnson, Pfizer Inc., Merck & Co., Inc, and AstraZeneca.

The Biologics market report provides the complete details of various market trends and adoption rate in various segments and across the globe. The major trends, drivers, restraints, and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the biologics market.

This report also provides the competitive landscape of the leading players in Global Biologics market and this study will help the vendors to understand their competitor’s landscape. The report can also be tailored as per the specific info required by the users. The customization of the report is available based on countries, vendor profiles, enterprise and vertical wise.

Report Scope:

  • Product Type
    • Monoclonal antibodies
    • Recombinant Proteins
    • Vaccines
    • Cell therapy
    • Gene therapy
    • Others
  • Source
    • Microbial source
    • Mammalian source
  • Application
    • Cancer
    • Infectious disease
    • Haematological disorder
    • Immunological disorder
    • Others
  • Regions
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

Request for TOC at

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Secondary & Primary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting


Market related information is congregated from both secondary and primary sources. Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

For more details on Research Methodology kindly click here to Engage with our Analyst.

  • 10
    Enquiry Hours